KIROPRAKTISK KLINIK ISHØJ ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  3.6% 2.2% 1.9% 2.2% 1.7%  
Credit score (0-100)  54 65 68 65 72  
Credit rating  BBB BBB A BBB A  
Credit limit (kDKK)  0.0 0.1 0.4 0.1 4.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  3,168 3,563 3,368 3,773 4,366  
EBITDA  1,414 1,444 673 917 1,255  
EBIT  1,219 1,151 382 653 960  
Pre-tax profit (PTP)  1,252.5 1,201.7 435.6 607.1 906.5  
Net earnings  977.3 934.4 338.8 474.9 708.0  
Pre-tax profit without non-rec. items  1,252 1,202 436 607 906  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  911 1,163 1,018 1,296 1,001  
Shareholders equity total  1,231 1,665 1,504 1,679 2,087  
Interest-bearing liabilities  887 845 642 3,738 2,873  
Balance sheet total (assets)  2,796 3,282 2,782 5,964 5,541  

Net Debt  856 825 595 3,684 2,853  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,168 3,563 3,368 3,773 4,366  
Gross profit growth  8.9% 12.5% -5.5% 12.0% 15.7%  
Employees  6 6 6 8 7  
Employee growth %  50.0% 0.0% 0.0% 33.3% -12.5%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,796 3,282 2,782 5,964 5,541  
Balance sheet change%  112.6% 17.4% -15.2% 114.4% -7.1%  
Added value  1,414.3 1,443.9 672.9 944.0 1,254.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  377 -42 -435 13 -589  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  38.5% 32.3% 11.3% 17.3% 22.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  61.4% 40.3% 15.1% 18.5% 19.6%  
ROI %  88.1% 52.1% 19.3% 21.1% 21.5%  
ROE %  103.7% 64.5% 21.4% 29.8% 37.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  44.0% 50.8% 54.1% 28.2% 37.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  60.5% 57.2% 88.4% 401.6% 227.4%  
Gearing %  72.1% 50.7% 42.7% 222.6% 137.7%  
Net interest  0 0 0 0 0  
Financing costs %  2.0% 2.7% 2.8% 9.1% 6.7%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.0 2.0 2.2 1.3 1.5  
Current Ratio  2.0 2.0 2.2 1.3 1.5  
Cash and cash equivalent  31.6 19.9 47.7 53.6 20.2  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  918.6 1,071.8 962.5 951.6 1,582.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  236 241 112 118 179  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  236 241 112 115 179  
EBIT / employee  203 192 64 82 137  
Net earnings / employee  163 156 56 59 101